Skip to content

Clinical trials

Liver Cirrhosis trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Country / region: Puerto Rico Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20122
20171
20181
20201
20222
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Gilead Sciences2
Boehringer Ingelheim1
Eli Lilly and Company1
GlaxoSmithKline1
Hepion Pharmaceuticals, Inc.1
Madrigal Pharmaceuticals, Inc.1
Mallinckrodt1
SciClone Pharmaceuticals1
Tobira Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis12
Non-alcoholic Fatty Liver Disease4
Fatty Liver1
Fibrosis1
Hepatic Encephalopathy1
Hepatitis C1
Hepatitis C, Chronic1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.